Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
Teva Pharmaceuticals Prepares for Upcoming Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America
Teva Canada commercialises Aermony RespiClick for bronchial asthma
Teva Inhalation Aerosol Approved by FDA for Children 4 and Over - Pharmaceutical Processing World
Anything but Generic: A map for Selling to Teva Pharmaceuticals
How Teva Is Leveraging IBM Watson To Improve Healthcare
Teva Announces FDA Approval of 2 New Respiclick Maintenance Inhalers - Drug Discovery and Development
EU nod for Teva's asthma biologic - PharmaTimes
Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment - Basel St 5, Petah Tikva, Israel
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva Pharmaceuticals on Twitter: "Are you attending #AAAAI21? Be sure to visit our virtual booth to learn more about Teva's work to improve care for #asthma and #COPD patients. https://t.co/2vgkja3Zli https://t.co/ybwPHkAdOX" /
Teva Pharmaceuticals Europe - Home | Facebook
Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round | Fierce Pharma
Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
Teva Pharmaceuticals and IBM Partner to Build Global e-Health Solutions on the IBM Watson Health Cloud
Teva Pharmaceuticals releases its prescription ProAir Digihaler in the US | MobiHealthNews
Strategy for inhaled corticosteroid use leads to better asthma outcomes, according to national study of Black and Latinx patients | UIC Today
Teva Launches 2 New Digital Maintenance Inhalers
Teva Announces FDA approval of AirDuo® Digihaler™
